Search Tag: Abbott
2022 25 Apr
Now available for use with both Apple and Android devices, the app helps people track pain relief during the treatment journey with neurostimulation devices Updated app provides doctors with an at-a-glance assessment of their patients while on their treatment journey Abbott announced that it has launched an upgraded version of its NeuroSphere™...Read more
2021 10 Dec
Abbott announced that its Board of Directors has elected Chief Executive Officer Robert B. Ford as Chairman of the Board, effective today. Miles D. White , executive chairman and former CEO, will step down from the Abbott Board effective today and will retire after a remarkable 38-year career with the Company. "We're grateful for Miles' leadership...Read more
2021 05 Oct
The Consumer Technology Association (CTA)® announced that Abbott President and CEO Robert B. Ford will deliver a keynote at CES® 2022 , the world’s most influential technology event. This marks the first time in CES history that a healthcare company will take the mainstage for a keynote at the show. Ford will be joined on stage by a diverse group...Read more
2019 15 Oct
It’s also the number one for health start-ups: an explosion of innovations and exciting ideas for improving health More dynamic, more digital and more networked than ever: the medical industry is taking strides into the future. If you want to be in peak condition for taking on the challenges of tomorrow, you need to keep your finger on the pulse,...Read more
2019 15 Mar
It is undeniable that laboratory testing is vital for the diagnosis, prognostication and therapeutic monitoring of human disease. Despite the many advances made for achieving a high degree of quality and safety in the analytical part of diagnostic testing, many hurdles in the total testing process remain, for example in the preanalytical phase when...Read more
2019 21 Jan
Based on an Abbott-sponsored symposium “Diagnostics, Data and Integrated Clinical Care – From Insight to Action” presented at European Association of Hospital Managers (EAHM) congress, Cascais, Portugal, 27th September 2018. Introduction Pressure on healthcare systems continues to rise as the world’s population grows and lives longer;...Read more
2019 21 Jan
How can a clinical decision support system help to achieve measurably better healthcare outcomes? The Collaboratory” reflects the transformation through collaboration that Abbott wants to ignite by working in partnership with clients. Abbott supports healthcare organizations to overcome their challenges and materialize their future state vision,...Read more
2018 21 Aug
Emilie Neukom Director of Marketing for EMEA, Abbott Diagnostics The global healthcare sector has been undergoing constant upheaval for over a decade. Aging populations, budget restrictions and a lack of skilled staff are making it harder than ever before to deliver high quality healthcare, and laboratory diagnostic services have suffered...Read more
2018 21 Aug
David Humphreys Global Head of Health Policy, The Economist Intelligence Unit (EIU) Abbott recently commissioned a study by the Economist Intelligence Unit – supported by research partners IPSOS and Acuity – to examine the laboratory’s current influence and perception, as well as to explore initiatives that could increase the impact of...Read more
2018 21 Aug
Khosrow Shotorbani CEO and founder of the lab 2.0 Strategic Services Healthcare systems globally are undergoing a paradigm shift from ‘sick care’ to ‘well care’. With budgets becoming ever more stretched, cost avoidance through disease prevention and early intervention are the only viable option – we can no longer afford to simply care...Read more
2018 21 Aug
Paul Jülicher Director International Health Economics & Outcomes Research, Abbott Diagnostics Matt Sawtell General Manager Nordics, Abbott Diagnostics Unleashing the value of IVD testing The value of in vitro diagnostic services is like beauty – it's very much in the eye of the beholder. From a community perspective,...Read more
2017 12 Jan
Abbott has announced its Alinity™ s System for blood and plasma screening received CE Mark and is now available in Europe and other countries that recognize CE Mark. The new testing solution is designed to screen blood and plasma faster and more efficiently within a smaller footprint than Abbott's current systems. In a testing specialty that can require extensive...Read more
2016 09 Dec
INTRODUCTION A study of emergency admissions in England found that over a quarter of admissions did not require an overnight stay (length of stay [LoS] of zero). 1 This suggests that many emergency patients could benefit from ambulatory emergency care (AEC). 1 Fundamental to AEC is the identification and management of patients with...Read more
2016 28 Apr
Abbott Laboratories is taking over St. Jude Medical Inc. in a deal worth $25 bln that will create a giant in the cardio-related devices market. The two NYSE-listed companies said in a joint announcement that the combination will “create a premier medical device leader and strengthen Abbott’s long-term growth potential.” They added that the...Read more
2016 18 Feb
ABBOTT GAINS LEADERSHIP IN THE $5.5 BILLION POINT OF CARE SEGMENT, BROADENS DIAGNOSTICS FOOTPRINT AND ENHANCES ACCESS TO FAST-GROWING DIAGNOSTICS CHANNELS - Transaction expected to be immediately accretive to Abbott's ongoing earnings per share upon close - Acquisition will provide access to new product applications, channels and geographies -...Read more
2015 31 Dec
Kristoffer Strålin, MD, PhD , is Associate Professor and Senior Consultant at the Department of Infectious Diseases, Karolinska Institute, Stockholm, Sweden. Karolinska Institute is a world renowned medical university, which has the mission of improving people’s health through research and education. Together with Karolinska University Hospital,...Read more
2014 16 Sep
A new study suggests a pioneering testing technology could reduce hospital stays by up to eight days and lower annual health care costs for people with serious infections by approximately $2.2 million (€1.5 million / £1.2 million).[1] The cost reductions are based on a health economic model from the RApid Diagnosis of Infections in the CriticAlly...Read more
2014 15 Sep
Abbott, a global healthcare organisation, has been named the second leading company in the pharmaceutical industry by the Dow Jones Sustainability Index (DJSI) for the second consecutive year. This is one of the most prestigious global benchmarks for corporate responsibility and sustainability. Abbott is an industry group leader in healthcare...Read more
2013 04 Sep
A recent health economics and outcomes study, conducted by leading health economists and supported by Abbott, found that oral nutritional supplements provided to patients during hospitalization were associated with significant reductions in length of stay and hospitalization cost. Additionally, the 30-day readmission risk was significantly reduced for...Read more
2013 01 Aug
Abbott announced on July 30, 2013, promising results from a study evaluating its High Sensitive Troponin-I (hsTnI) assay presented at this year’s American Association for Clinical Chemistry (AACC) annual meeting in Houston, Texas. The study, conducted by researchers at Brigham and Women’s Hospital, demonstrated that Abbott’s hsTnI test (currently...Read more
2013 04 Jun
Abbott previewed a prototype for the company’s next-generation blood screening system at an event coinciding with this year’s International Society of Blood Transfusion (ISBT) Meeting in Amsterdam from June 2-5, 2013. Abbott’s new system features a user-responsive design based upon insights provided by leading blood screening experts from around the...Read more